A bill to amend title XVIII of the Social Security Act to ensure more appropriate payment amounts for drugs and biologicals under part B of the Medicare Program by excluding customary prompt pay discounts extended to wholesalers from the manufacturer's average sales price.
Latest action · Jun 9, 2009 Read twice and referred to the Committee on Finance. (text of measure as introduced: CR S6384)
Progress
Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.
- IntroducedJun 9, 2009
- Passed SenateNot reached
- Passed HouseNot reached
- To the PresidentNot reached
- Became lawNot reached
Summary
Amends title XVIII (Medicare) of the Social Security Act with respect to the use of average sales price methodology for calculating payments for drugs and biologicals under Medicare part B (Supplementary Medical Insurance).
Excludes from the manufacturer's average sales price when calculating such payments any customary prompt pay discounts extended to wholesalers.
Cosponsors 10
Members who signed on, in the order they did. Signatures ran from Jun 9, 2009 to Dec 9, 2010; 1 is an original cosponsor, there from the day it was introduced.
| Seat | Cosponsor | Signed on | |
|---|---|---|---|
| R-KS | Pat Roberts | Original | Jun 9, 2009 |
| D-AR | Blanche L. Lincoln | Jun 10, 2009 | |
| D-OH | Sherrod Brown | Jun 18, 2009 | |
| R-UT | Robert F. Bennett | Jun 23, 2009 | |
| D-NJ | Frank R. Lautenberg | Jul 20, 2009 | |
| D-PA | Robert P. Casey Jr. | Aug 4, 2009 | |
| R-TN | Lamar Alexander | Sep 29, 2009 | |
| R-NC | Richard Burr | Feb 24, 2010 | |
| D-MI | Debbie Stabenow | Mar 10, 2010 | |
| D-NC | Kay R. Hagan | Dec 9, 2010 |
Committees 1
Where it was sent and what each committee and subcommittee did with it, in order.
| Chamber | Committee | What it did |
|---|---|---|
| Senate | Finance Committee | Referred Jun 9, 2009 |
Actions 3
Everything that happened, newest first.
- Jun 9, 2009Introduced in Senate
- Jun 9, 2009Sponsor introductory remarks on measure. (CR S6383-6384)
- Jun 9, 2009Read twice and referred to the Committee on Finance. (text of measure as introduced: CR S6384)
In the Congressional Record 1
Days the Record’s own index lists this bill, newest first, with the pages and the members it names. Pages starting H are the House, S the Senate, E Extensions of Remarks.
| Where | In the Record | Members | Date |
|---|---|---|---|
| Senate | Debate and remarks S6383Text printed S6383, S6384 | Arlen Specter D-PA (text) | Jun 9, 2009 |
Related bills 1
Companion bills and other measures the record links to this one.
| Bill | Title | Relationship | Latest action |
|---|---|---|---|
| HR 1392 | To amend title XVIII of the Social Security Act to ensure more appropriate payment amounts for drugs and biologicals under part B of the Medicare Program by excluding customary prompt pay discounts extended to wholesalers from the manufacturer's average sales price. | Identical bill | Mar 10, 2009 |
Titles 1
Every title it has carried, official and short, at each stage.
- Official Title as Introduced
- A bill to amend title XVIII of the Social Security Act to ensure more appropriate payment amounts for drugs and biologicals under part B of the Medicare Program by excluding customary prompt pay discounts extended to wholesalers from the manufacturer's average sales price.
Subjects
Assigned by the Library of Congress. Policy area: Health.
Text 1
Each version as it was printed, newest first.
- Jun 9, 2009Introduced in Senate
Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.